Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Expanded Access Program (EAP) for Obecabtagene Autoleucel (Obe-Cel) Out-of-Specification (OOS) in Adult Patients with Acute Lymphoblastic Leukemia

Disease Sites:

Leukemia

Staging:

N/A

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Oluwole, Olalekan

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

11-11-2025

Trial Type:

Treatment

Protocol ID:

VICC-CTT25006

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available